Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:can_metastasize_to |
lungs
lymph nodes peritoneum |
| gptkbp:caused_by |
ascites
|
| gptkbp:displacement |
gptkb:clear_cell_carcinoma
endometrioid carcinoma mucinous carcinoma |
| gptkbp:has_style |
serous cystadenocarcinoma
serous papillary carcinoma |
| https://www.w3.org/2000/01/rdf-schema#label |
Serous carcinoma
|
| gptkbp:is_associated_with |
BRC A1 mutations
BRC A2 mutations tumor microenvironment changes |
| gptkbp:is_characterized_by |
high-grade histology
invasive growth pattern presence of psammoma bodies serous fluid production |
| gptkbp:is_considered |
aggressive cancer
|
| gptkbp:is_linked_to |
environmental factors
inflammation hormonal factors increased CA-125 levels |
| gptkbp:is_monitored_by |
follow-up imaging
CA-125 testing |
| gptkbp:is_often_used_in |
ovary
postmenopausal women endometrium |
| gptkbp:is_part_of |
ovarian cancer
endometrial cancer gynecological cancers malignant neoplasms |
| gptkbp:is_recognized_by |
histopathological examination
|
| gptkbp:is_studied_in |
gptkb:vaccine
clinical trials targeted therapies |
| gptkbp:is_subject_to |
genetic testing
|
| gptkbp:is_used_for |
abdominal pain
bloating urinary symptoms |
| gptkbp:occurs_in |
uterus
bilateral ovaries |
| gptkbp:scientific_classification |
epithelial ovarian cancer
type II endometrial cancer |
| gptkbp:social_responsibility |
imaging studies
biopsy poor prognosis |
| gptkbp:treatment |
gptkb:paclitaxel
gptkb:hospital gptkb:carboplatin radiation therapy chemotherapy |
| gptkbp:bfsParent |
gptkb:Epithelial_ovarian_cancer
|
| gptkbp:bfsLayer |
5
|